Verition Fund Management »

Context Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $33k 16k 2.01

More positions owned by Verition Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
DTE Energy Company (DTE)
Sempra Energy (SRE)
Truist Financial Corp equities Put Option (TFC)
PPL Corporation Call Option (PPL)
Old National Ban (ONB)
Broadcom Put Option (AVGO)
NiSource (NI)

View all positions for Verition Fund Management

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics